Search and Track the Federal Register
Department or Agency:
Show:
Regulations Filed: All Dates
Between and
Full Text (optional):

[Federal Register: August 25, 2009 (Volume 74, Number 163)]
[Notices]               
[Page 42877]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr25au09-44]                         

-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy

 
Notice of Intent to Grant a Partially Exclusive Patent License; 
Sanofi Pasteur S.A.

AGENCY: Department of the Navy, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to Sanofi Pasteur S.A., a revocable, nonassignable, partially 
exclusive license to practice worldwide the Government owned inventions 
described in U.S. Patent Application Serial No. 11/340,003 with 
inventor Stephen J. Savarino filed on 10 January 2006, entitled 
``Adhesin as Immunogen Against Enterotoxigenic E. coli'' and its 
related PCT/US2006/000660 National Phase applications in Australia, 
Canada, Europe, Japan and India filed 11 July 2007; and U.S. Patent 
Application Serial No. 11/988,598 with inventors Stephen J. Savarino, 
Randall K. Holmes and Michael Jobling filed on 11 January 2007, 
entitled ``Adhesin-Enterotoxin Chimera Based Composition Against 
Enterotoxigenic E. coli'' and its related PCT/US2007/000712 National 
Phase applications in Australia, Canada, Europe, and Japan filed 10 
January 2008 in the field of ``Protection against ETEC (Enterotoxigenic 
Escherichia Coli) associated diarrhea in both endemic zones and for 
travelers, including the military.''

DATES: Anyone wishing to object to the grant of this license has 
fifteen (15) days from the date of this notice to file written 
objections along with supporting evidence, if any. Written objections 
are to be filed with the Office of Technology Transfer, Naval Medical 
Research Center, 503 Robert Grant Ave., Silver Spring, MD 20910-7500, 
telephone (301) 319-7428.

ADDRESSES: Written objections are to be filed with the Office of 
Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500.

FOR FURTHER INFORMATION CONTACT: Dr. Charles Schlagel, Director, Office 
of Technology Transfer, Naval Medical Research Center, 503 Robert Grant 
Ave., Silver Spring, MD 20910-7500, telephone (301) 319-7428.

    Dated: August 18, 2009.
A.M. Vallandingham,
Lieutenant Commander, Judge Advocate General's Corps, U.S. Navy, 
Federal Register Liaison Officer.
[FR Doc. E9-20363 Filed 8-24-09; 8:45 am]

BILLING CODE 3810-FF-P